1. Home
  2. EYPT vs UHT Comparison

EYPT vs UHT Comparison

Compare EYPT & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • UHT
  • Stock Information
  • Founded
  • EYPT 1987
  • UHT 1986
  • Country
  • EYPT United States
  • UHT United States
  • Employees
  • EYPT N/A
  • UHT N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • UHT Real Estate Investment Trusts
  • Sector
  • EYPT Industrials
  • UHT Real Estate
  • Exchange
  • EYPT Nasdaq
  • UHT Nasdaq
  • Market Cap
  • EYPT 594.5M
  • UHT 496.9M
  • IPO Year
  • EYPT 2005
  • UHT N/A
  • Fundamental
  • Price
  • EYPT $7.48
  • UHT $37.27
  • Analyst Decision
  • EYPT Strong Buy
  • UHT
  • Analyst Count
  • EYPT 8
  • UHT 0
  • Target Price
  • EYPT $25.71
  • UHT N/A
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • UHT 74.7K
  • Earning Date
  • EYPT 03-06-2025
  • UHT 02-25-2025
  • Dividend Yield
  • EYPT N/A
  • UHT 7.89%
  • EPS Growth
  • EYPT N/A
  • UHT 3.98
  • EPS
  • EYPT N/A
  • UHT 1.31
  • Revenue
  • EYPT $45,713,000.00
  • UHT $99,899,000.00
  • Revenue This Year
  • EYPT N/A
  • UHT N/A
  • Revenue Next Year
  • EYPT N/A
  • UHT N/A
  • P/E Ratio
  • EYPT N/A
  • UHT $28.45
  • Revenue Growth
  • EYPT 7.50
  • UHT 3.43
  • 52 Week Low
  • EYPT $6.90
  • UHT $32.27
  • 52 Week High
  • EYPT $30.99
  • UHT $47.30
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • UHT 47.13
  • Support Level
  • EYPT $7.15
  • UHT $34.56
  • Resistance Level
  • EYPT $8.25
  • UHT $37.88
  • Average True Range (ATR)
  • EYPT 0.66
  • UHT 0.91
  • MACD
  • EYPT -0.01
  • UHT 0.27
  • Stochastic Oscillator
  • EYPT 22.01
  • UHT 76.99

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio which is located throughout the United States.

Share on Social Networks: